img

Global Poliomyelitis Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Poliomyelitis Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Polio vaccines are vaccines used to prevent poliomyelitis. There are two typesone that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
Poliomyelitis Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Poliomyelitis Vaccine market is projected to reach US$ 835.1 million in 2034, increasing from US$ 709.8 million in 2022, with the CAGR of 2.3% during the period of 2024 to 2034. Demand from VAPP and VDPV are the major drivers for the industry.
Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 91% market shares.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Poliomyelitis Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GSK
Sanofi-Pasteur
Merck
Crucell
China National Biotech Group
Eli Lilly
Segment by Type
Poliomyelitis Vaccine Ⅰ
Poliomyelitis Vaccine Ⅱ
Poliomyelitis Vaccine Ⅲ
Oral Poliomyelitis Vaccine

Segment by Application


VAPP
VDPV

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Poliomyelitis Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Poliomyelitis Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Poliomyelitis Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Poliomyelitis Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Poliomyelitis Vaccine introduction, etc. Poliomyelitis Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Poliomyelitis Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Poliomyelitis Vaccine Market Overview
1.1 Poliomyelitis Vaccine Product Overview
1.2 Poliomyelitis Vaccine Market Segment by Type
1.2.1 Poliomyelitis Vaccine Ⅰ
1.2.2 Poliomyelitis Vaccine Ⅱ
1.2.3 Poliomyelitis Vaccine Ⅲ
1.2.4 Oral Poliomyelitis Vaccine
1.3 Global Poliomyelitis Vaccine Market Size by Type
1.3.1 Global Poliomyelitis Vaccine Market Size Overview by Type (2018-2034)
1.3.2 Global Poliomyelitis Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Poliomyelitis Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Poliomyelitis Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Poliomyelitis Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Poliomyelitis Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Poliomyelitis Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Poliomyelitis Vaccine Sales Breakdown by Type (2018-2024)
2 Global Poliomyelitis Vaccine Market Competition by Company
2.1 Global Top Players by Poliomyelitis Vaccine Sales (2018-2024)
2.2 Global Top Players by Poliomyelitis Vaccine Revenue (2018-2024)
2.3 Global Top Players by Poliomyelitis Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Poliomyelitis Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Poliomyelitis Vaccine Market Competitive Situation and Trends
2.5.1 Poliomyelitis Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Poliomyelitis Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Poliomyelitis Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Poliomyelitis Vaccine Market
2.8 Key Manufacturers Poliomyelitis Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Poliomyelitis Vaccine Status and Outlook by Region
3.1 Global Poliomyelitis Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Poliomyelitis Vaccine Historic Market Size by Region
3.2.1 Global Poliomyelitis Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Poliomyelitis Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Poliomyelitis Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Poliomyelitis Vaccine Forecasted Market Size by Region
3.3.1 Global Poliomyelitis Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Poliomyelitis Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Poliomyelitis Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Poliomyelitis Vaccine by Application
4.1 Poliomyelitis Vaccine Market Segment by Application
4.1.1 VAPP
4.1.2 VDPV
4.2 Global Poliomyelitis Vaccine Market Size by Application
4.2.1 Global Poliomyelitis Vaccine Market Size Overview by Application (2018-2034)
4.2.2 Global Poliomyelitis Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Poliomyelitis Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Poliomyelitis Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Poliomyelitis Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Poliomyelitis Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Poliomyelitis Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Poliomyelitis Vaccine Sales Breakdown by Application (2018-2024)
5 North America Poliomyelitis Vaccine by Country
5.1 North America Poliomyelitis Vaccine Historic Market Size by Country
5.1.1 North America Poliomyelitis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Poliomyelitis Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Poliomyelitis Vaccine Sales in Value by Country (2018-2024)
5.2 North America Poliomyelitis Vaccine Forecasted Market Size by Country
5.2.1 North America Poliomyelitis Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Poliomyelitis Vaccine Sales in Value by Country (2024-2034)
6 Europe Poliomyelitis Vaccine by Country
6.1 Europe Poliomyelitis Vaccine Historic Market Size by Country
6.1.1 Europe Poliomyelitis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Poliomyelitis Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Poliomyelitis Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Poliomyelitis Vaccine Forecasted Market Size by Country
6.2.1 Europe Poliomyelitis Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Poliomyelitis Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Poliomyelitis Vaccine by Region
7.1 Asia-Pacific Poliomyelitis Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Poliomyelitis Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Poliomyelitis Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Poliomyelitis Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Poliomyelitis Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Poliomyelitis Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Poliomyelitis Vaccine Sales in Value by Region (2024-2034)
8 Latin America Poliomyelitis Vaccine by Country
8.1 Latin America Poliomyelitis Vaccine Historic Market Size by Country
8.1.1 Latin America Poliomyelitis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Poliomyelitis Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Poliomyelitis Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Poliomyelitis Vaccine Forecasted Market Size by Country
8.2.1 Latin America Poliomyelitis Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Poliomyelitis Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Poliomyelitis Vaccine by Country
9.1 Middle East and Africa Poliomyelitis Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Poliomyelitis Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Poliomyelitis Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Poliomyelitis Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Poliomyelitis Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Poliomyelitis Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Poliomyelitis Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 GSK Poliomyelitis Vaccine Products Offered
10.1.5 GSK Recent Development
10.2 Sanofi-Pasteur
10.2.1 Sanofi-Pasteur Company Information
10.2.2 Sanofi-Pasteur Introduction and Business Overview
10.2.3 Sanofi-Pasteur Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Sanofi-Pasteur Poliomyelitis Vaccine Products Offered
10.2.5 Sanofi-Pasteur Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Merck Poliomyelitis Vaccine Products Offered
10.3.5 Merck Recent Development
10.4 Crucell
10.4.1 Crucell Company Information
10.4.2 Crucell Introduction and Business Overview
10.4.3 Crucell Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Crucell Poliomyelitis Vaccine Products Offered
10.4.5 Crucell Recent Development
10.5 China National Biotech Group
10.5.1 China National Biotech Group Company Information
10.5.2 China National Biotech Group Introduction and Business Overview
10.5.3 China National Biotech Group Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 China National Biotech Group Poliomyelitis Vaccine Products Offered
10.5.5 China National Biotech Group Recent Development
10.6 Eli Lilly
10.6.1 Eli Lilly Company Information
10.6.2 Eli Lilly Introduction and Business Overview
10.6.3 Eli Lilly Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Eli Lilly Poliomyelitis Vaccine Products Offered
10.6.5 Eli Lilly Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Poliomyelitis Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Poliomyelitis Vaccine Industrial Chain Analysis
11.4 Poliomyelitis Vaccine Market Dynamics
11.4.1 Poliomyelitis Vaccine Industry Trends
11.4.2 Poliomyelitis Vaccine Market Drivers
11.4.3 Poliomyelitis Vaccine Market Challenges
11.4.4 Poliomyelitis Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Poliomyelitis Vaccine Distributors
12.3 Poliomyelitis Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Poliomyelitis Vaccine Ⅰ
Table 2. Major Company of Poliomyelitis Vaccine Ⅱ
Table 3. Major Company of Poliomyelitis Vaccine Ⅲ
Table 4. Major Company of Oral Poliomyelitis Vaccine
Table 5. Global Poliomyelitis Vaccine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Poliomyelitis Vaccine Sales by Type (2018-2024) & (K Units)
Table 7. Global Poliomyelitis Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Poliomyelitis Vaccine Sales by Type (2018-2024) & (US& Million)
Table 9. Global Poliomyelitis Vaccine Market Share in Value by Type (2018-2024)
Table 10. Global Poliomyelitis Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Poliomyelitis Vaccine Sales by Type (2024-2034) & (K Units)
Table 12. Global Poliomyelitis Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Poliomyelitis Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Poliomyelitis Vaccine Sales Market Share in Value by Type (2024-2034)
Table 15. Global Poliomyelitis Vaccine Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Poliomyelitis Vaccine Sales by Type (2018-2024) & (K Units)
Table 17. North America Poliomyelitis Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Poliomyelitis Vaccine Sales (K Units) by Type (2018-2024)
Table 19. Europe Poliomyelitis Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Poliomyelitis Vaccine Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Poliomyelitis Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Poliomyelitis Vaccine Sales (K Units) by Type (2018-2024)
Table 23. Latin America Poliomyelitis Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Poliomyelitis Vaccine Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Poliomyelitis Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Poliomyelitis Vaccine Sales by Company (2018-2024) & (K Units)
Table 27. Global Poliomyelitis Vaccine Sales Share by Company (2018-2024)
Table 28. Global Poliomyelitis Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Poliomyelitis Vaccine Revenue Share by Company (2018-2024)
Table 30. Global Market Poliomyelitis Vaccine Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Poliomyelitis Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Poliomyelitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Poliomyelitis Vaccine as of 2022)
Table 34. Date of Key Manufacturers Enter into Poliomyelitis Vaccine Market
Table 35. Key Manufacturers Poliomyelitis Vaccine Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Poliomyelitis Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Poliomyelitis Vaccine Sales by Region (2018-2024) & (K Units)
Table 39. Global Poliomyelitis Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Poliomyelitis Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Poliomyelitis Vaccine Sales Market Share in Value by Region (2018-2024)
Table 42. Global Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Poliomyelitis Vaccine Sales by Region (2024-2034) & (K Units)
Table 44. Global Poliomyelitis Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Poliomyelitis Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Poliomyelitis Vaccine Sales Market Share in Value by Region (2024-2034)
Table 47. Global Poliomyelitis Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Poliomyelitis Vaccine Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Poliomyelitis Vaccine Sales by Application (2018-2024) & (K Units)
Table 50. Global Poliomyelitis Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Poliomyelitis Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Poliomyelitis Vaccine Sales Market Share in Value by Application (2018-2024)
Table 53. Global Poliomyelitis Vaccine Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Poliomyelitis Vaccine Sales by Application (2024-2034) & (K Units)
Table 55. Global Poliomyelitis Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Poliomyelitis Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Poliomyelitis Vaccine Sales Market Share in Value by Application (2024-2034)
Table 58. Global Poliomyelitis Vaccine Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Poliomyelitis Vaccine Sales by Application (2018-2024) (K Units)
Table 60. North America Poliomyelitis Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Poliomyelitis Vaccine Sales by Application (2018-2024) (K Units)
Table 62. Europe Poliomyelitis Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Poliomyelitis Vaccine Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Poliomyelitis Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Poliomyelitis Vaccine Sales by Application (2018-2024) (K Units)
Table 66. Latin America Poliomyelitis Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Poliomyelitis Vaccine Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Poliomyelitis Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Poliomyelitis Vaccine Sales by Country (2018-2024) & (K Units)
Table 70. North America Poliomyelitis Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Poliomyelitis Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Poliomyelitis Vaccine Sales Market Share in Value by Country (2018-2024)
Table 73. North America Poliomyelitis Vaccine Sales by Country (2024-2034) & (K Units)
Table 74. North America Poliomyelitis Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Poliomyelitis Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Poliomyelitis Vaccine Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Poliomyelitis Vaccine Sales by Country (2018-2024) & (K Units)
Table 78. Europe Poliomyelitis Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Poliomyelitis Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Poliomyelitis Vaccine Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Poliomyelitis Vaccine Sales by Country (2024-2034) & (K Units)
Table 82. Europe Poliomyelitis Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Poliomyelitis Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Poliomyelitis Vaccine Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Poliomyelitis Vaccine Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Poliomyelitis Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Poliomyelitis Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Poliomyelitis Vaccine Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Poliomyelitis Vaccine Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Poliomyelitis Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Poliomyelitis Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Poliomyelitis Vaccine Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Poliomyelitis Vaccine Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Poliomyelitis Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Poliomyelitis Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Poliomyelitis Vaccine Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Poliomyelitis Vaccine Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Poliomyelitis Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Poliomyelitis Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Poliomyelitis Vaccine Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Poliomyelitis Vaccine Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Poliomyelitis Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Poliomyelitis Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Poliomyelitis Vaccine Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Poliomyelitis Vaccine Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Poliomyelitis Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Poliomyelitis Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Poliomyelitis Vaccine Sales Market Share in Value by Country (2024-2034)
Table 109. GSK Company Information
Table 110. GSK Introduction and Business Overview
Table 111. GSK Poliomyelitis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. GSK Poliomyelitis Vaccine Product
Table 113. GSK Recent Development
Table 114. Sanofi-Pasteur Company Information
Table 115. Sanofi-Pasteur Introduction and Business Overview
Table 116. Sanofi-Pasteur Poliomyelitis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Sanofi-Pasteur Poliomyelitis Vaccine Product
Table 118. Sanofi-Pasteur Recent Development
Table 119. Merck Company Information
Table 120. Merck Introduction and Business Overview
Table 121. Merck Poliomyelitis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. Merck Poliomyelitis Vaccine Product
Table 123. Merck Recent Development
Table 124. Crucell Company Information
Table 125. Crucell Introduction and Business Overview
Table 126. Crucell Poliomyelitis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Crucell Poliomyelitis Vaccine Product
Table 128. Crucell Recent Development
Table 129. China National Biotech Group Company Information
Table 130. China National Biotech Group Introduction and Business Overview
Table 131. China National Biotech Group Poliomyelitis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. China National Biotech Group Poliomyelitis Vaccine Product
Table 133. China National Biotech Group Recent Development
Table 134. Eli Lilly Company Information
Table 135. Eli Lilly Introduction and Business Overview
Table 136. Eli Lilly Poliomyelitis Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Eli Lilly Poliomyelitis Vaccine Product
Table 138. Eli Lilly Recent Development
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. Poliomyelitis Vaccine Market Trends
Table 142. Poliomyelitis Vaccine Market Drivers
Table 143. Poliomyelitis Vaccine Market Challenges
Table 144. Poliomyelitis Vaccine Market Restraints
Table 145. Poliomyelitis Vaccine Distributors List
Table 146. Poliomyelitis Vaccine Downstream Customers
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Poliomyelitis Vaccine Product Picture
Figure 2. Global Poliomyelitis Vaccine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Poliomyelitis Vaccine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Poliomyelitis Vaccine Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Poliomyelitis Vaccine Ⅰ
Figure 6. Global Poliomyelitis Vaccine Ⅰ Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Poliomyelitis Vaccine Ⅱ
Figure 8. Global Poliomyelitis Vaccine Ⅱ Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Poliomyelitis Vaccine Ⅲ
Figure 10. Global Poliomyelitis Vaccine Ⅲ Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Oral Poliomyelitis Vaccine
Figure 12. Global Oral Poliomyelitis Vaccine Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Global Poliomyelitis Vaccine Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Poliomyelitis Vaccine Sales Market Share by Type in 2022 & 2034
Figure 15. North America Poliomyelitis Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. North America Poliomyelitis Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Europe Poliomyelitis Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Europe Poliomyelitis Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Poliomyelitis Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Poliomyelitis Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Latin America Poliomyelitis Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Poliomyelitis Vaccine Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Poliomyelitis Vaccine Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Poliomyelitis Vaccine Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Poliomyelitis Vaccine Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Poliomyelitis Vaccine Revenue in 2022
Figure 27. Poliomyelitis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of VAPP
Figure 29. Global VAPP Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of VDPV
Figure 31. Global VDPV Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Global Poliomyelitis Vaccine Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Poliomyelitis Vaccine Sales Market Share by Application in 2022 & 2034
Figure 34. North America Poliomyelitis Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. North America Poliomyelitis Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Europe Poliomyelitis Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Europe Poliomyelitis Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Poliomyelitis Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Poliomyelitis Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Latin America Poliomyelitis Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Poliomyelitis Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Poliomyelitis Vaccine Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Poliomyelitis Vaccine Manufacturing Cost Structure
Figure 45. Poliomyelitis Vaccine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries